We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$9.41B
AUM Growth
-$1.41B
Cap. Flow
-$1.76B
Cap. Flow %
-18.7%
Top 10 Hldgs %
34.48%
Holding
1,981
New
418
Increased
359
Reduced
342
Closed
619

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$68.2M
2
DAL icon
Delta Air Lines
DAL
+$56M
3
ARGX icon
argenx
ARGX
+$51.7M
4
MRNA icon
Moderna
MRNA
+$48.7M
5
NVDA icon
NVIDIA
NVDA
+$46.4M

Sector Composition

Rank Sector Weight
1 Healthcare 11.12%
2 Technology 4.7%
3 Energy 4.53%
4 Industrials 3.84%
5 Consumer Discretionary 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNAI
1651
Lunai Bioworks
LNAI
$10.6M
-403
Closed -$85.3K
REXR icon
1652
CALL
Rexford Industrial Realty
REXR
$8.56B
-8,100
Closed -$407K
REXR icon
1653
Rexford Industrial Realty
REXR
$8.56B
-2,699
Closed -$136K
RGLD icon
1654
Royal Gold
RGLD
$17.1B
-6,750
Closed -$822K
RGP icon
1655
Resources Connection
RGP
$130M
-42,807
Closed -$563K
RGTI icon
1656
Rigetti Computing
RGTI
$5.02B
-100,000
Closed -$153K
RHP icon
1657
Ryman Hospitality Properties
RHP
$8.44B
-11,200
Closed -$1.29M
RIG icon
1658
Transocean
RIG
$5.82B
-135,184
Closed -$781K
RJF icon
1659
Raymond James Financial
RJF
$32.9B
-49,242
Closed -$6.32M
RLAY icon
1660
Relay Therapeutics
RLAY
$4.08B
-101,563
Closed -$843K
RMBS icon
1661
Rambus
RMBS
$10.6B
-11,682
Closed -$722K
RDNW
1662
RideNow Group
RDNW
$251M
-10,800
Closed -$69.8K
RNST icon
1663
Renasant Corp
RNST
$4.06B
-29,200
Closed -$915K
ROK icon
1664
PUT
Rockwell Automation
ROK
$51.5B
-2,000
Closed -$583K
ROOT icon
1665
Root
ROOT
$934M
-3,700
Closed -$226K
RPAY icon
1666
Repay Holdings
RPAY
$316M
-59,000
Closed -$649K
RPRX icon
1667
Royalty Pharma
RPRX
$25.9B
-137,000
Closed -$4.16M
RRX icon
1668
Regal Rexnord
RRX
$14.3B
-1,196
Closed -$215K
RVMD icon
1669
Revolution Medicines
RVMD
$40.5B
-30,422
Closed -$981K
RXRX icon
1670
Recursion Pharmaceuticals
RXRX
$1.61B
-10,110
Closed -$101K
RYTM icon
1671
Rhythm Pharmaceuticals
RYTM
$7.16B
-68,566
Closed -$2.97M
S icon
1672
CALL
SentinelOne
S
$6.26B
-20,000
Closed -$466K
S icon
1673
SentinelOne
S
$6.26B
-4,872
Closed -$114K
S icon
1674
PUT
SentinelOne
S
$6.26B
-20,000
Closed -$466K
SACH
1675
Sachem Capital Corp
SACH
$38.8M
-32,500
Closed -$145K

Similar funds

Jefferies Financial Group's Q2 2024 Portfolio in Review

As of Q2 2024, Jefferies Financial Group held 1,981 positions worth $9.41B, down 13% from $10.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jefferies Financial Group withdrew a net $1.76B in Q2 2024, closing 619 positions and reducing 342 holdings. Its most notable exit was Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 8.4% a quarter earlier, followed by Technology and Energy.

Against the trend, Jefferies Financial Group opened a new position in Sprinklr worth $22.7M.

  • Jefferies Financial Group's largest Q2 2024 buy was Sprinklr: 2,355,000 shares worth $22.7M.
  • Jefferies Financial Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $151M increase.
  • Jefferies Financial Group's biggest Q2 2024 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $68.2M.
  • Jefferies Financial Group fully exited Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant in Q2 2024, selling an estimated $24.3M.
  • Jefferies Financial Group's ten largest holdings make up 34% of its $9.41B portfolio in Q2 2024.
  • Jefferies Financial Group opened 418 new positions and closed 619 in Q2 2024.
  • Jefferies Financial Group's portfolio value fell 13% quarter-over-quarter to $9.41B.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.